{
    "Trade/Device Name(s)": [
        "SPOTFIRE RSP Pos & Neg Controls",
        "SPOTFIRE RSP Negative Control"
    ],
    "Submitter Information": "Maine Molecular Quality Controls, Inc.",
    "510(k) Number": "K241289",
    "Predicate Device Reference 510(k) Number(s)": [
        "K233611"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "May 6, 2024",
    "Summary Letter Received Date": "May 7, 2024",
    "Submission Date": "April 28, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed Quality Control Material For Clinical Microbiology Assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Bordetella parapertussis",
        "Bordetella pertussis",
        "Chlamydia pneumoniae",
        "Mycoplasma pneumoniae",
        "Streptococcus dysgalactiae (Group C/G Strep)",
        "Streptococcus pyogenes (Group A Strep)",
        "Adenovirus",
        "Coronavirus SARS-CoV-2",
        "Coronavirus (seasonal)",
        "Human Metapneumovirus",
        "Human Rhinovirus/Enterovirus",
        "Influenza A Subtype H1-2009",
        "Influenza A Subtype H3",
        "Influenza B",
        "Parainfluenza Virus",
        "Respiratory Syncytial Virus"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Throat swab"
    ],
    "Specimen Container(s)": [
        "Transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "BIOFIRE SPOTFIRE System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid testing",
        "Reverse transcription",
        "Amplification",
        "Detection",
        "Identification"
    ],
    "Methodologies": [
        "In vitro nucleic acid testing",
        "Quality control monitoring"
    ],
    "Submission Type(s)": [
        "Quality control material",
        "Panel",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for SPOTFIRE RSP Pos & Neg Controls as external quality control material for BIOFIRE SPOTFIRE respiratory nucleic acid testing panels",
    "Indications for Use Summary": "External positive and negative assayed quality control to monitor performance of in vitro nucleic acid testing procedures for qualitative detection of respiratory pathogens using BIOFIRE SPOTFIRE panel assays",
    "fda_folder": "Microbiology"
}